Albumin creatinine ration (ACR)
Showing 1 - 25 of 2,242
Rate and Risk Signature in Semirural Sub-Saharan Africa
Not yet recruiting
- Chronic Kidney Diseases
- +6 more
-
Bagamoyo, Pwani, TanzaniaBagamoyo District Hospital
May 19, 2023
Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Chronic Kidney Diseases
- Empagliflozin 10 MG
- Placebo
- (no location specified)
Oct 30, 2023
Early Screening and Diagnosis of CKD
Recruiting
- Kidney; Disease (Functional)
- Chronic Kidney Disease
- 99mTc-DTPA
-
Nanjing, Jiangsu, ChinaNanjing First Hospital, Nanjing Medical University
Apr 5, 2022
"Association of Proteinuria and Progression of Kidney
Completed
- Change in Albumin to Creatinine Ratio and Glomerular Filtration Rate
- Progression of Kidney Failure and or All-cause Mortality
- no intervention study
-
Creteil, FranceHenri Mondor Hospital
Jun 1, 2022
Diabetic Nephropathies Trial (Intensively integrated care of microvascular risk factors in the intervention group)
Not yet recruiting
- Diabetic Nephropathies
- Intensively integrated care of microvascular risk factors in the intervention group
- (no location specified)
Jul 26, 2021
Called SMART-Finder to Look for People With Increased Amounts of
Not yet recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Disease
- Finerenone (Kerendia, BAY94-8862)
- Type 2 DM drugs
-
Multiple Locations, GermanyMany locations
Jan 13, 2023
Fetuin A asPredictor of Deterioration of Renal Function in
Recruiting
- Arterial Hypertension
- No intervention.
-
Ostrava, Czech Republic, CzechiaUniversity Hospital Ostrava, - Department of Internal Medicine a
Jul 18, 2023
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
Not yet recruiting
- Diabetic Kidney Disease
- cathepsin S and chromogranin A
- (no location specified)
Oct 5, 2023
Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Vitamin K 2
- (no location specified)
Jul 4, 2023
Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Co-Enzyme Q10
- (no location specified)
Jul 4, 2023
T2DM (Type 2 Diabetes), Metformin, SGLT2-Inhibitors Trial in Matsumoto (Tofogliflozin, Metformin)
Recruiting
- T2DM (Type 2 Diabetes Mellitus)
- +2 more
-
Matsumoto, Nagano, JapanShinshu University
Jul 21, 2022
Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)
Not yet recruiting
- Multiple Myeloma
- Bone marow biopsy and aspiration
- biochemical and heamatological tests
- (no location specified)
Aug 9, 2023
Pmm2-CDG, CDG1A Trial in Rochester, Philadelphia, Seattle (Placebo, Acetazolamide)
Active, not recruiting
- Pmm2-CDG
- CDG1A
- Placebo
- Acetazolamide
-
Rochester, Minnesota
- +2 more
Jan 12, 2023
Diabetic Nephropathy Trial in Phoenix (Losartan, Placebo)
Chronic Kidney Diseases Trial in Houston (1. Welcome package, 2. Welcome information (phone or text), 3. Produce delivery +
Not yet recruiting
- Chronic Kidney Diseases
- 1. Welcome package
- +4 more
-
Houston, Texas
- +2 more
Jul 31, 2023
Diabetic Kidney Disease Trial in United States (TMX-049, Placebo)
Liver Transplant; Complications, Vitamin D Deficiency Trial (vitamin D supplementation, control)
Not yet recruiting
- Liver Transplant; Complications
- Vitamin D Deficiency
- vitamin D supplementation
- control
- (no location specified)
Oct 5, 2022
Enteral and Supplement Feeds Adverse Reaction, Peritonitis; Acute Trial (study group)
Not yet recruiting
- Enteral and Supplement Feeds Adverse Reaction
- Peritonitis; Acute
- study group
- (no location specified)
Aug 11, 2023
Diabetes, Kidney Transplant; Complications Trial (Empagliflozin 25 MG, Linagliptin 5 mg Oral Tablet)
Not yet recruiting
- Diabetes Mellitus
- Kidney Transplant; Complications
- Empagliflozin 25 MG
- Linagliptin 5 mg Oral Tablet
- (no location specified)
Oct 18, 2023
Liver Cirrhosis, Acute Kidney Injury Trial in New Delhi (Albumin, Standard Medical Treatment)
Recruiting
- Liver Cirrhosis
- Acute Kidney Injury
- Albumin
- Standard Medical Treatment
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Jan 27, 2022
Fibromyalgia Syndrome Parameters With Disease-Pain Severity and
Recruiting
- Fibromyalgia Syndrome
- +2 more
- Questionary
-
Istanbul, Üsküdar, TurkeyÖzlem Kaleoğlu
Apr 28, 2023
Liver Disease Chronic Trial in Stockholm (stable isotopes)
Not yet recruiting
- Liver Disease Chronic
- stable isotopes
-
Stockholm, SwedenKarolinska Institutet
Jul 23, 2023
Heart Failure, Chronic Kidney Disease Trial in Worldwide (AZD9977, Dapagliflozin)
Recruiting
- Heart Failure
- Chronic Kidney Disease
-
Hot Springs National Park, Arkansas
- +279 more
Feb 1, 2023